MedTrace Logo

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

NCT06015932 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-07-29

No results posted yet for this study

Summary

This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.

Conditions

  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm

Interventions

BEHAVIORAL

Cognitive Behavior Therapy

Participate in CBCSM group sessions

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

Principal Investigators

  • Shawna L. Ehlers, Ph.D., L.P. · Mayo Clinic in Rochester

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06015932 on ClinicalTrials.gov